| Literature DB >> 21199224 |
S K Gupta1, S McGrath, K Rogers, J Attia, G Lewis, S Viswanathan, M Saul, L Allen.
Abstract
Radioiodine therapy (RIT) is an accepted treatment for hyperthyroidism and a 555-MBq (15-mCi) dose is frequently used. We aimed to assess treatment outcome with this dose, and to identify predictors of successful treatment. An analysis of 478 treated patients demonstrated an overall four-month cure rate of 79.5%; success rate was higher in patients with toxic multinodular goitre, solitary toxic adenoma, a smaller thyroid or less severe disease. This information may be of further assistance if variation in the dose of RIT is considered.Entities:
Mesh：
Substances：
Year: 2010 PMID： 21199224 DOI： 10.1111/j.1445-5994.2010.02348.x
Source DB: PubMed Journal: Intern Med J ISSN： 1444-0903 Impact factor: 2.048